Radiofrequency ablation of colorectal hepatic metastases

Journal of Surgical Oncology

Volumn 102, Issue 8, 2010, Pages 978-987

  Guenette, Jeffrey P ^a   Dupuy, Damian E ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

colorectal cancer; liver metastases; minimally invasive therapy; thermal coagulation

Indexed keywords

ABDOMINAL SURGERY; COLORECTAL CANCER; HUMAN; IMAGING; LAPAROSCOPIC SURGERY; LIVER METASTASIS; LIVER TUMOR; MINIMALLY INVASIVE PROCEDURE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL APPROACH;

CATHETER ABLATION; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 78650672417     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21658     Document Type: Review

References (83)

1. Stangl R, Altendorf-Hofmann A, Charnley RM, et al.: Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-1410.
2. Knudsen AR, Kannerup AS, Mortensen FV, et al.: Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy. Acta Radiol 2009; 50: 716-721.
3. Fernandez FG, Drebin JA, Linehan DC, et al.: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004; 240: 438-447; discussion 447-450.
4. Pawlik TM, Scoggins CR, Zorzi D, et al.: Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722; discussion 722-724.
5. Abdalla EK, Vauthey JN, Ellis LM, et al.: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825; discussion 825-827.
6. Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766.
7. Livraghi T, Solbiati L, Meloni MF, et al.: Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003; 226: 441-451.
8. Timmerman RD, Bizekis CS, Pass HI, et al.: Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009; 59: 145-170.
9. Sorensen SM, Mortensen FV, Nielsen DT,: Radiofrequency ablation of colorectal liver metastases: Long-term survival. Acta Radiol 2007; 48: 253-258.
10. Hildebrand P, Leibecke T, Kleemann M, et al.: Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome. Eur J Surg Oncol 2006; 32: 430-434.
11. Mulier S, Ni Y, Jamart J, et al.: Radiofrequency ablation versus resection for resectable colorectal liver metastases: Time for a randomized trial? Ann Surg Oncol 2008; 15: 144-157.
12. Park IJ, Kim HC, Yu CS, et al.: Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol 2008; 15: 227-232.
13. Stang A, Fischbach R, Teichmann W, et al.: A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 2009; 45: 1748-1756.
14. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318; discussion 318-321.
15. Iannitti DA, Dupuy DE, Mayo-Smith WW, et al.: Hepatic radiofrequency ablation. Arch Surg 2002; 137: 422-426; discussion 427.
16. Gillams AR, Lees WR,: Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 2005; 30: 419-426.
17. Lambert LA, Colacchio TA, Barth RJ, Jr.:, Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000; 135: 473-479; discussion 479-480.
18. Pawlik TM, Schulick RD, Choti MA,: Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008; 13: 51-64.
19. Alberts SR, Horvath WL, Sternfeld WC, et al.: Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group phase II study. J Clin Oncol 2005; 23: 9243-9249.
20. Solbiati L, Ierace T, Tonolini M, et al.: Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51: S19-S23.
21. Quaia E, D'Onofrio M, Palumbo A, et al.: Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: Diagnostic performance and confidence. Eur Radiol 2006; 16: 1599-1609.
22. Bruegel M, Gaa J, Waldt S, et al.: Diagnosis of hepatic metastasis: Comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 2008; 191: 1421-1429.
23. Ichikawa T, Haradome H, Hachiya J, et al.: Diffusion-weighted MR imaging with a single-shot echoplanar sequence: Detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998; 170: 397-402. (Pubitemid 28083846)
24. Okada Y, Ohtomo K, Kiryu S, et al.: Breath-hold T2-weighted MRI of hepatic tumors: Value of echo planar imaging with diffusion-sensitizing gradient. J Comput Assist Tomogr 1998; 22: 364-371.
25. Nasu K, Kuroki Y, Nawano S, et al.: Hepatic metastases: Diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-130.
26. Namimoto T, Yamashita Y, Sumi S, et al.: Focal liver masses: Characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997; 204: 739-744.
27. Yamada I, Aung W, Himeno Y, et al.: Diffusion coefficients in abdominal organs and hepatic lesions: Evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210: 617-623.
28. Taouli B, Vilgrain V, Dumont E, et al.: Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: Prospective study in 66 patients. Radiology 2003; 226: 71-78.
29. Coenegrachts K, Delanote J, Ter Beek L, et al.: Improved focal liver lesion detection: Comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007; 80: 524-531.
30. Bipat S, van Leeuwen MS, Comans EF, et al.: Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-Meta-analysis. Radiology 2005; 237: 123-131.
31. Onishi H, Murakami T, Kim T, et al.: Hepatic metastases: Detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006; 239: 131-138.
32. Wildi SM, Gubler C, Hany T, et al.: Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. J Clin Ultrasound 2008; 36: 20-26.
33. Wood BJ, Locklin JK, Viswanathan A, et al.: Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. J Vasc Interv Radiol 2007; 18: 9-24.
34. Yamakado K, Nakatsuka A, Akeboshi M, et al.: Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 2003; 14: 1183-1186.
35. Terraz S, Cernicanu A, Lepetit-Coiffe M, et al.: Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: Progress in targeting and preliminary observations with temperature monitoring. Eur Radiol 2010; 20: 886-897.
36. Lepetit-Coiffe M, Laumonier H, Seror O, et al.: Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: Initial results in nine patients, including follow-up. Eur Radiol 2010; 20: 193-201.
37. Goldberg SN, Hahn PF, Tanabe KK, et al.: Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9: 101-111.
38. Lencioni R, Crocetti L, Cioni D, et al.: Percutaneous radiofrequency ablation of hepatic colorectal metastases: Technique, indications, results, and new promises. Invest Radiol 2004; 39: 689-697.
39. Machi J, Oishi AJ, Sumida K, et al.: Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: Evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 2006; 12: 318-326.
40. Garrean S, Hering J, Saied A, et al.: Radiofrequency ablation of primary and metastatic liver tumors: A critical review of the literature. Am J Surg 2008; 195: 508-520.
41. Meijerink MR, van den Tol P, van Tilborg AA, et al.: Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: Initial clinical experience. Eur J Radiol 2009.
42. Ahmad A, Chen SL, Kavanagh MA, et al.: Radiofrequency ablation of hepatic metastases from colorectal cancer: Are newer generation probes better? Am Surg 2006; 72: 875-879.
43. Wright AS, Lee FT, Jr., Mahvi DM,: Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003; 10: 275-283.
44. Wolf FJ, Beland MD, Grand DJ, et al.: Microwave ablation of hepatic malignancies: Effectiveness & safety in 70 patients. Chicago, IL: RSNA. 2009.
45. Goldberg SN, Gazelle GS, Mueller PR,: Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174: 323-331.
46. Sapareto SA, Dewey WC,: Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787-800.
47. Lepock JR,: How do cells respond to their thermal environment? Int J Hyperthermia 2005; 21: 681-687.
48. Goldberg SN, Gazelle GS, Halpern EF, et al.: Radiofrequency tissue ablation: Importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3: 212-218.
49. Mertyna P, Goldberg W, Yang W, et al.: Thermal ablation a comparison of thermal dose required for radiofrequency-, microwave-, and laser-induced coagulation in an ex vivo bovine liver model. Acad Radiol 2009; 16: 1539-1548.
50. Livraghi T, Goldberg SN, Monti F, et al.: Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202: 205-210.
51. Abitabile P, Maurer CA,: Radiofrequency ablation of liver tumors: A novel needle perfusion technique enhances efficiency. J Surg Res 2010; 20: 532-537.
52. Schirmang TC, Dupuy DE,: Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip radiofrequency ablation system. Expert Rev Med Devices 2007; 4: 803-814.
53. Liang P, Wang Y, Yu X, et al.: Malignant liver tumors: Treatment with percutaneous microwave ablation-Complications among cohort of 1136 patients. Radiology 2009; 251: 933-940.
54. Iannitti DA, Martin RC, Simon CJ, et al.: Hepatic tumor ablation with clustered microwave antennae: The US Phase II Trial. HPB (Oxford) 2007; 9: 120-124.
55. Liu CH, Arellano RS, Uppot RN, et al.: Radiofrequency ablation of hepatic tumours: Effect of post-ablation margin on local tumour progression. Eur Radiol 2010; 20: 877-885.
56. Rhim H, Dodd GD III, Chintapalli KN, et al.: Radiofrequency thermal ablation of abdominal tumors: Lessons learned from complications. Radiographics 2004; 24: 41-52.
57. Wagner JS, Adson MA, Van Heerden JA, et al.: The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508.
58. Goldberg SN, Grassi CJ, Cardella JF, et al.: Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20: S377-S390.
59. Goldberg SN, Gazelle GS, Compton CC, et al.: Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation. Cancer 2000; 88: 2452-2463.
60. Nijkamp MW, van der Bilt JD, de Bruijn MT, et al.: Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg 2009; 249: 814-823.
61. Liu SY, Lee KF, Lai PB,: Needle track seeding: A real hazard after percutaneous radiofrequency ablation for colorectal liver metastasis. World J Gastroenterol 2009; 15: 1653-1655.
62. Stigliano R, Marelli L, Yu D, et al.: Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 2007; 33: 437-447.
63. Livraghi T, Lazzaroni S, Meloni F, et al.: Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005; 92: 856-858.
64. Goldberg SN, Solbiati L, Halpern EF, et al.: Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 2000; 11: 1069-1075.
65. Goto E, Tateishi R, Shiina S, et al.: Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol 2010; 44: 374-380.
66. Thomas KT, Bream PR, Jr., Berlin J, et al.: Use of percutaneous drainage to treat hepatic abscess after radiofrequency ablation of metastatic pancreatic adenocarcinoma. Am Surg 2004; 70: 496-499.
67. Curley SA,: Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003; 10: 338-347.
68. Dodd GD III, Napier D, Schoolfield JD, et al.: Percutaneous radiofrequency ablation of hepatic tumors: Postablation syndrome. AJR Am J Roentgenol 2005; 185: 51-57.
69. Gervais DA, Goldberg SN, Brown DB, et al.: Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol 2009; 20: S342-S347.
70. Murakami T, Shibata T, Ishida T, et al.: Percutaneous microwave hepatic tumor coagulation with segmental hepatic blood flow occlusion in seven patients. AJR Am J Roentgenol 1999; 172: 637-640.
71. Yamagami T, Kato T, Tanaka O, et al.: Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy. J Vasc Interv Radiol 2005; 16: 549-554.
72. Lammers T, Hennink WE, Storm G,: Tumour-targeted nanomedicines: Principles and practice. Br J Cancer 2008; 99: 392-397.
73. Berber E, Pelley R, Siperstein AE,: Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: A prospective study. J Clin Oncol 2005; 23: 1358-1364.
74. Solbiati L, Livraghi T, Nahum Goldberg S,: Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 2001; 221: 159-166.
75. De Baere TJ, Elias D, Ducreux M, et al.: Percutaneous radiofrequency of liver metastases: Single center experience over a five year period. Proc Am Soc Clin Oncol 2003; 22: abstr 1387.
76. Solbiati L, Ierace T, Tonolini M, et al.: Long-term survival of patients treated with radiofrequency ablation for liver colorectal metastases: Improved outcome with increasing experience. Presented at the 2003 Radiological Society of North America Scientific Assembly and Annual Meeting in Chicago, IL.
77. Pereira P, Clasen S, Hoffmann R, et al.: Long-term survival after CT and MR-guided percutaneous radiofrequency ablation of colorectal metastases: Clinical results of the German study group. Presented at the 2006 Radiological Society of North America Scientific Assembly and Annual Meeting in Chicago, IL.
78. Solbiati L, Ierace T, Brioschi M, et al.: Radiofrequency ablation of liver metastases of colorectal origin with intention to treat: Local response rate and long-term survival over 7-year follow-up. Presented at the 2006 Radiological Society of North America Scientific Assembly and Annual Meeting in Chicago, IL.
79. Yu N, Kim YJ, Raman S, et al.: Intraoperative radiofrequency ablation of unresectable liver metastases from colorectal carcinoma: Long-term results in 50 patients. Presented at the 2006 Radiological Society of North America Scientific Assembly and Annual Meeting in Chicago, IL.
80. Siperstein AE, Berber E, Ballem N, et al.: Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 2007; 246: 559-565.
81. Solbiati L, Lerace T, Cova L,: Five and 7-year survival of patients with inoperable and potentially resectable liver colorectal metastases treated with radiofrequency ablation. Presented at the 2008 Radiological Society of North America Scientific Assembly and Annual Meeting in Chicago, IL.
82. Veltri A, Sacchetto P, Tosetti I, et al.: Radiofrequency ablation of colorectal liver metastases: Small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 2008; 31: 948-956.
83. Gillams AR, Lees WR,: Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19: 1206-1213.